It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
The Food and Drug Administration approved the prescription cannabidiol medicine Monday to treat rare and severe forms of epilepsy.
FDA Commissioner Dr. Scott Gottlieb also issued an immediate statement saying this wasn’t an approval of marijuana, in general — and said anyone wanting to use cannabis-based products to treat disease must prove they are safe and that they work.
originally posted by: Mandroid7
a reply to: TEOTWAWKIAIFF
No, it's a weed, period.
Nothing needs to be given, especially the gd rights they weren't allowed to take away in the first place.
It's time to get gov back to it's original purpose, back to the constitution, remove all the bs laws they illegally have granted themselves power to create.
It's all bs, greedy, middlemen who want to not work and extract everyones wealth.
It goes deeper than the weed issue. They have everything rigged.
From all the laws to what you are allowed to produce. (Patent system, regulations, taxes, etc)
It's starting to choke out our country.
We are not represented. We are controlled and kept down by these market rigging and wealth stealing scum.
Sorry, rant not directed at you, I'm just starting to get sick of the bs game.
originally posted by: ATruGod
The Food and Drug Administration approved the prescription cannabidiol medicine Monday to treat rare and severe forms of epilepsy.
FDA Commissioner Dr. Scott Gottlieb also issued an immediate statement saying this wasn’t an approval of marijuana, in general — and said anyone wanting to use cannabis-based products to treat disease must prove they are safe and that they work.
FDA approves cannabis-based drug CBD for epilepsy
So the weed that has no Medical use has now been approved for a specific Medical use.
Of course thats not an "approval" of the plant.
Think They will let real Research begin?
Based on the potential for abuse, the Drug Enforcement Administration (DEA) categorizes chemicals into five schedules, with Schedule 1 substances - like marijuana and heroin - considered the most deadly and deemed to have no medical benefits.
As a result, Epidiolex’s launch remains at the discretion of the DEA, which must now evaluate the drug and consider reclassifying it as a substance that has medical properties, so as to allow GW to begin selling it.
GW said it expects the reclassification to occur within 90 days. The company has not yet set a price for the drug and said it would work with insurance providers to ensure the medicine would be covered under health plans.